Shopping Cart
Remove All
Your shopping cart is currently empty
RTI-13951-33 hydrochloride is a potent, selective, and brain-penetrant GPR88 agonist, exhibiting an EC50 of 25 nM in vitro cAMP functional assay. It significantly reduces alcohol reinforcement and intake behaviors in rats [1].

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | Inquiry | 3-6 months | 3-6 months | |
| 50 mg | Inquiry | 3-6 months | 3-6 months | |
| 100 mg | Inquiry | 3-6 months | 3-6 months |
| Description | RTI-13951-33 hydrochloride is a potent, selective, and brain-penetrant GPR88 agonist, exhibiting an EC50 of 25 nM in vitro cAMP functional assay. It significantly reduces alcohol reinforcement and intake behaviors in rats [1]. |
| Targets&IC50 | GPR88:(EC50)25 nM |
| In vitro | RTI-13951-33 is a potent and selective GPR88 agonist that effectively crosses the blood-brain barrier, demonstrating a significant effect with an EC50 value of 25 nM in GPR88 cAMP functional assays. It also increases [35S]-GTPγS binding in the mouse striatum with an EC50 of 535 nM, a response absent in GPR88 knockout (KO) mice. Despite its primary activity, RTI-13951-33 exhibits weak affinities for the kappa opioid receptor (KOR; Ki, 2.29 μM), the vesicular monoamine transporter (VMAT; Ki, 4.23 μM), and a moderate affinity for the serotonin transporter (SERT; Ki, 0.75 μM). However, it demonstrates poor inhibition of SERT, with an IC50 of 25.1±2.7 μM. |
| In vivo | RTI-13951-33 (10 and 20 mg/kg, i.p.) reduces alcohol lever responses in a rat model of alcohol self-administration dose-dependently, demonstrating sufficient brain penetration with a half-life of 48 minutes in plasma and 87 minutes in brain [1]. |
| Synonyms | RTI-13951-33 hydrochloride (2244884-08-8 free base) |
| Molecular Weight | 532.5 |
| Formula | C28H35Cl2N3O3 |
| Relative Density. | no data available |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 125 mg/mL (234.74 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween-80+45% Saline: 3.3 mg/mL (6.2 mM), Sonication is recommeded. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.